South Africa to produce Pfizer/BioNTech Covid-19 vaccine

Covid-19 vaccine

Under the agreement, Cape Town-based Biovac will complete the last step in the manufacturing process of the Pfizer/BioNTech vaccine. 

Photo credit: Joel Saget | AFP

What you need to know:

  • The project will take time to get off the ground however, with the first African-finished Pfizer vaccines not expected before 2022.
  • Once up and running, Biovac is set to churn out more than 100 million doses annually.

Covid-19 vaccine makers BioNTech and Pfizer on Wednesday said they had found a South African partner to produce their jab on the African continent for the first time.

Welcome!

You're all set to enjoy unlimited Prime content.